Abstract
Objectives: Epidemiological studies have suggested a protective effect of vegetables and fruits on urinary tract cancer but the possible protective nutrients are unknown. We studied the effect of alpha-tocopherol (a form of vitamin E) and beta-carotene supplementation on urinary tract cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
Methods: A total of 29,133 male smokers aged 50–69 years from southwestern Finland were randomly assigned to receive alpha-tocopherol (50 mg), beta-carotene (20 mg), both agents, or a placebo daily for 5–8 years (median 6.1 years). Incident urothelial cancers (bladder, ureter, and renal pelvis; n = 169) and renal cell cancers (n = 102) were identified through the nationwide cancer registry. The diagnoses were centrally confirmed by review of medical records and pathology specimens. The supplementation effects were estimated using a proportional hazards model.
Results: Neither alpha-tocopherol nor beta-carotene affected the incidence of urothelial cancer, relative risk 1.1 (95% confidence interval (CI) 0.8–1.5) and 1.0 (95% CI 0.7–1.3), respectively, or the incidence of renal cell cancer, relative risk 1.1 (95% CI 0.7–1.6) and 0.8 (95% CI 0.6–1.3), respectively.
Conclusion: Long-term supplementation with alpha-tocopherol and beta-carotene has no preventive effect on urinary tract cancers in middle-aged male smokers.
Similar content being viewed by others
References
WHO (1997) The World Health Report. Geneva: World Health Organization.
Ross RK, Jones PA, Yu MC (1996) Bladder cancer epidemiology and pathogenesis. Semin Oncol 23: 536–545.
IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans (1986) Vol. 38: Tobacco Smoking. Lyon: IARC.
Motzer RJ, Bander NH, Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335: 865–875.
La Vecchia C, Negri E (1996) Nutrition and bladder cancer. Cancer Causes Control 7: 95–100.
Wolk A, Lindblad P, Adami HO (1996) Nutrition and renal cell cancer. Cancer Causes Control 7: 5–18.
Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci EL (1999) Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst 91: 605–613.
The ATBC Cancer Prevention Study Group (1994) The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4: 1–10.
The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029–1035.
Pietinen P, Hartman AM, Haapa E, et al. (1988) Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 128: 655–666.
Milne DB, Botnen J (1986) Retinol, alpha-tocopherol, lycopene, and alpha-and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 32: 874–876.
Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. (1992) American Joint Committee on Cancer. Manual for Staging of Cancer, 4th edn. Philadelphia: Lippincott.
Cox DR, Oakes D (1984) Analysis of Survival Data. London: Chapman & Hall.
Albanes D, Heinonen OP, Taylor PR, et al. (1996) α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88: 1560–1570.
Omenn GS, Goodman GE, Thornquist MD, et al. (1996) Risk factors for lung cancer and for intervention e.ects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88: 1550–1559.
Hennekens CH, Buring JE, Manson JE, et al. (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334: 1145–1149.
Moon RC, Mehta RG, Rao KVN (1994) Retinoids and cancer in experimental animals. In: Sporn MB, Roberts AB, Goodman DS, eds. The Retinoids: Biology, Chemistry, and Medicine, 2nd edn. New York: Raven Press, pp. 573–595.
Alfthan O, Tarkkanen J, Gröhn P, Heinonen E, Pyrhönen S, Säilä K (1983) Tigason® (etretinate) in prevention of recurrence of superficial bladder tumors. Eur Urol 9: 6–9.
Studer UE, Jenzer S, Biedermann C, et al. (1995) Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Eur Urol 28: 284–290.
Pedersen H, Wolf H, Kromann Jensen S, et al. (1984) Administration of a retinoid as prophylaxis of recurrent non-invasive bladder tumors. Scand J Urol Nephrol 18: 121–123.
Messing EM, Vaillancourt A (1990) Hematuria screening for bladder cancer. J Occup Med 32: 838–845.
Steiner M (1999) Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease. Nutr Rev 57: 306–309.
Foresman WH, Messing EM (1997) Bladder cancer: natural history, tumor markers, and early detection strategies. Semin Surg Oncol 13: 299–306.
Comstock GW, Bush TL, Helzlsouer K (1992) Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 135: 115–121.
Schoenberg JB, Stemhagen A, Mogielnicki AP, Altman R, Abe T, Mason TJ (1984) Case-control study of bladder cancer in New Jersey. I. Occupational exposures in white males. J Natl Cancer Inst 72: 973–981.
Cohen SM (1998) Urinary bladder carcinogenesis. Toxicol Pathol 26: 121–127.
World Cancer Research Fund in association with American Institute for Cancer Research (1997) Food, Nutrition and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, pp. 330–337.
Wolk A, Gridley G, Niwa S, et al. (1996) International renal cell cancer study. VII. Role of diet. Int J Cancer 65: 67–73.
Tavani A, Pregnolato A, Violante A, La Vecchia C, Negri E (1997) Attributable risks for kidney cancer in Northern Italy. Eur J Cancer Prev 6: 195–199.
Yuan JM, Gago-Dominguez M, Castelao JE, Hankin JH, Ross RK, Yu MC (1998) Cruciferous vegetables in relation to renal cell carcinoma. Int J Cancer 77: 211–216.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Virtamo, J., Edwards, B.K., Virtanen, M. et al. Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland). Cancer Causes Control 11, 933–939 (2000). https://doi.org/10.1023/A:1026546803917
Issue Date:
DOI: https://doi.org/10.1023/A:1026546803917